Effect of Dextrose Prolotherapy on Pain Intensity, Disability, and Plantar Fascia Thickness in Unilateral Plantar Fasciitis
Autor: | Basak Mansiz-Kaplan, Secil Pervane-Vural, Baris Nacir, Hakan Genç, Burcu Duyur-Cakit |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male 030506 rehabilitation Lidocaine Visual analogue scale medicine.medical_treatment Plantar fasciitis Physical Therapy Sports Therapy and Rehabilitation Injections law.invention Disability Evaluation 03 medical and health sciences 0302 clinical medicine Double-Blind Method Randomized controlled trial law medicine Humans Prospective Studies Fasciitis Saline Pain Measurement business.industry Prolotherapy Rehabilitation Middle Aged medicine.disease Glucose Treatment Outcome medicine.anatomical_structure Fasciitis Plantar Anesthesia Chronic Disease Female Plantar fascia medicine.symptom 0305 other medical science business 030217 neurology & neurosurgery medicine.drug |
Zdroj: | American Journal of Physical Medicine & Rehabilitation. 99:318-324 |
ISSN: | 1537-7385 0894-9115 |
DOI: | 10.1097/phm.0000000000001330 |
Popis: | OBJECTIVE The aim of the study was to evaluate the efficacy of dextrose prolotherapy in the treatment of chronic resistant plantar fasciitis through comparison with a control group. DESIGN In this double-blind, randomized, controlled study, the patients were divided into two groups. The prolotherapy group (n = 30) was administered 5 ml of 30% dextrose, 4 ml of saline, and 1 ml of 2% lidocaine mixture (15% dextrose solution) and the control group was given 9 ml of saline and 1 ml of 2% lidocaine mixture twice at a 3-wk interval. During the 15-wk follow-up period, pain intensity was measured using the visual analog scale during activity and at rest. The foot function index was used to measure pain and disability. The plantar fascia thickness was measured by ultrasonography. The measurements were undertaken before treatment and at posttreatment weeks 7 and 15. RESULTS Improvements in visual analog scale during activity, at rest, foot function index (all subgroups), and plantar fascia thickness measured at the 7th and 15th weeks were significantly higher in the prolotherapy group compared with the control group (P < 0.001). CONCLUSIONS Dextrose prolotherapy has efficacy up to 15 wks and can be used as an alternative method in the treatment of chronic resistant plantar fasciitis. |
Databáze: | OpenAIRE |
Externí odkaz: |